Diagnostic Performance of Fatty Liver Index for Hepatic Steatosis and its Association With Fibrosis in People Living With HIV

Key Points

• Evaluate the effectiveness of the fatty liver index (FLI) in diagnosing hepatic steatosis (HS) and its relationship with fibrosis in people living with HIV.
• Analyzed the diagnostic performance of the fatty liver index (FLI) against controlled attenuation parameter (CAP) measurements.
• Assessed concordance of FLI results with CAP in people living with HIV.
• Investigated the performance of FLI specifically in lean individuals within the population.
• FLI missed nearly half of the hepatic steatosis cases defined by CAP.
• Substantial limitations were found in screening for HS, especially in lean individuals.
• FLI is not reliable as a standalone tool for diagnosing hepatic steatosis.

Abstract